NCT02782481View on ClinicalTrials.gov

A Clinical Study Investigating the Efficacy, Tolerability, and Safety of Continuous Subcutaneous ND0612 Infusion Given as Adjunct Treatment to Oral Levodopa in Patients With Parkinson's Disease With Motor Fluctuations

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

August 31, 2016

Primary Completion Date

October 15, 2018

Study Completion Date

October 15, 2018

Conditions
Parkinson's Disease
Interventions
DRUG

ND0612

DRUG

Placebo

Trial Locations (1)

Unknown

Haddasah Ein Kerem Medical center, Jerusalem

Sponsors

Lead Sponsor

NeuroDerm Ltd.
All Listed Sponsors
lead

NeuroDerm Ltd.

INDUSTRY

NCT02782481 - A Clinical Study Investigating the Efficacy, Tolerability, and Safety of Continuous Subcutaneous ND0612 Infusion Given as Adjunct Treatment to Oral Levodopa in Patients With Parkinson's Disease With Motor Fluctuations | Biotech Hunter | Biotech Hunter